Cargando…
Potential Role of Anti-interleukin (IL)-6 Drugs in the Treatment of COVID-19: Rationale, Clinical Evidence and Risks
The epidemic due to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has been spreading globally, raising increasing concerns. This public health emergency has triggered a race to find medications to improve the prognosis of this disease. There is currently great interest in dr...
Autores principales: | Crisafulli, Salvatore, Isgrò, Valentina, La Corte, Laura, Atzeni, Fabiola, Trifirò, Gianluca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299248/ https://www.ncbi.nlm.nih.gov/pubmed/32557214 http://dx.doi.org/10.1007/s40259-020-00430-1 |
Ejemplares similares
-
Perispinal Etanercept for Post-Stroke Neurological and Cognitive Dysfunction: Scientific Rationale and Current Evidence
por: Ignatowski, Tracey A., et al.
Publicado: (2014) -
Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future
por: Łobocka, Małgorzata, et al.
Publicado: (2021) -
Establishing Patient Registries for Rare Diseases: Rationale and Challenges
por: Boulanger, Vanessa, et al.
Publicado: (2020) -
The New Era of Drug Therapy for Obesity: The Evidence and the Expectations
por: Jones, Ben J., et al.
Publicado: (2015) -
Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab
por: Chowdary, Pratima
Publicado: (2018)